Skip to main content
SpringerLink
Log in

Summary of Poster-Sessions

  • Chapter
Book cover Triazenes

  • 46 Accesses

Abstract

A. Varnavas and colleagues (16) have synthesized 1,3-di (4-carboxyphenyl) triazene (I), which is a diaryltriazene analogue of the antimetastatic agent DM-COOK (II).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Poster Titles

  1. Mechanisms of the cross-protective immunity induced by xenogenized against parental cells. R. Bianchi, M.C. Fioretti, L. Romani, M. Allegrucci and P. Puccetti. Dept. Exp. Med. and Bioch. Sci., Pharmacology Section, University of 06100 Perugia, Italy.

    Google Scholar 

  2. Effects of Dacarbazine (DTIC) on immunology in the human: I: High intermittent dose (HID). G. Cartei1, T. Giraldi2 and R. Carella1. 1 Divisione di Oncologia Medica, Ospedale Regionale, Udine and 2 Istituto di Farmacología, Università di Trieste.

    Google Scholar 

  3. Effect of Dacarbazine (DTIC) on immunology in the human: II: Low and intermediate chronic dose schedule (LDC,ICD). G. Cartei1, T. Giraldi2 and R. Carella1. 1 Divisione di Oncologia Medica, Ospedale Regionale, Udine and 2 Istituto di Farmacología, Università di Trieste.

    Google Scholar 

  4. Allorecognition of antigenic modifications induced by 4 (3-methyl-l-triazeno) benzoic acid (MTBA) in a human tumor line. S. D’Atri1, M. Tricarico2 and E. Bonmassar1. 1 Dep. of Experimental Medicine and Biochemical Sciences. II University of Rome, Rome, Italy and 2 Institute of Experimental Medicine, CNR, Rome Italy.

    Google Scholar 

  5. Comparative analysis of xenogenization patterns by chemicals belonging to different classes. P. Fuschiotti, U. Grohmann, L. Romani, P. Puccetti and M. C. Fioretti. Dept. Exp. Med. and Bioch. Sci., Pharmacology Section, University of 06100 Perugia, Italy.

    Google Scholar 

  6. Combination of BCNU DTIC VCR alternating with eis DDP Vinblastin and Bleomycin as primary chemotherapy in metastatic melanoma- a phase II trial. K. Kolaric, R. Tomek, Z. Mrsic and D. Zupanc. Central Institute for Tumors and Allied Diseases, Zagreb, Yugoslavia.

    Google Scholar 

  7. Correlation between chemosensitivity to CB10–277 and O6-alkyl-guanine-DNA alkyltransferase levels in human melanoma xenografts. J. M. Lunn1, B. J. Foster2, M. Jones2, J. Siraky2 and D. R. Newell2. 1Cancer Research Unit, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, England and2 Clinical Pharmacology, Institute of Cancer Research, Sutton, Surrey SM2 5NG., England.

    Google Scholar 

  8. Antimetastatic effect of dimethyltriazenes in mice bearing Lewis lung carcinoma of different metastatic potential. E. Raso, K. Lapis and L. Kopper. I. Insitute of Pathology and Experimental Cancer Research, Semmelweis Medical University, Ulloi ut 26, Budapest, H-1085 Hungary.

    Google Scholar 

  9. Activation and oxidative (MFO) N-demethylation of ring halogenated 3,3-dimethyl-l-phenyltriazenes. G. Sava1, S. Pacor1, F. Bregant1, V. Ceschia1 and G. F. Kolar2. 1 Institute of Pharmacology, Faculty of Pharmacy, University of Trieste, 1–34100 Trieste, Italy and 2 Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900 Heidelberg, F.R.G.

    Google Scholar 

  10. Antineoplastic action of p-(3-methyl-l-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK. G. Sava1, S. Zorzet1, L. Perissin1, S. Pacor1, V. Ceschia1, F. Bregant1, T. Giraldi1, A. Varnavas2, C. Nisi2 and L. Lassiani2. 1 Institute of Pharmacology and 2 Institute of Pharmaceutical Chemistry and Toxicology, Faculty of Pharmacy, University of Trieste, Italy.

    Google Scholar 

  11. Relation between methyltriazenes cytotoxicity and cell line ability to repair O6 alkylguanine. P. Taverna1, C. V. Catapano1, L. Citti2, M. Bonfanti1 and M. D’Incalci1. 1 Istituto “Mario Negri”, I–20157 Milano and 2 CNR Istituto Mutagenesi e Differenziamento, I–56100 Pisa.

    Google Scholar 

  12. Antitumor activity and aqueous stability of AVIS, a hydrosoluble diaryltriazene, related to the antimetastatic agent DM-COOK. A. Varnavas1, L. Lassiani1, C. Nisi1, S. Zorzet2, L. Perissin2 and G. Sava2. 1 Institute of Medicinal Chemistry and 2 Institute of Pharmacology, Faculty of Pharmacy, University of Trieste, Italy.

    Google Scholar 

  13. Synthesis and antitumor activity of hydrosoluble triazenes analogues of DM-COOK. A. Varnavas1, L. Lassiani1, C. Nisi1, S. Zorzet2, L. Perissin2, S. Pacor2, T. Giraldi2 and G. Sava2. 1 Institute of Medicinal Chemistry and 2 Institute of Pharmacology, Faculty of Pharmacy, University of Trieste, Italy.

    Google Scholar 

  14. Chromosome and DMA damage induced by the 1-p-(3-methyl-triazeno) benzoic acid potassium salt in human cells. P. Vernole1, D. Caporossi1, B. Tedeschi1, F. Zunino2, E. Bonmassar3 and B. Nicoletti1. 1 Dip. Sanità Pubblica & Biologia Cellulare, II Università di Roma, Via O. Raimondo 00173 Roma, Italia, 2 Ist. Naz. Studio & Cura Tumori, Milano, 3 Dip. Med. Sper., II Università di Roma.

    Google Scholar 

  15. Dacarbazine and Interferon alpha-2b combination in advanced malignant melanoma: a phase II study. S. Milani, G. Mustacchi, P. Sandri and M. Mansutti. Centro Oncológico, Via Pietà 19, 34127 Trieste, Italy.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental Medicine and Biochemical Sciences, II University of Rome, Italy

    E. Bonmassar

  2. Cancer Research Campaign, Pharmaceutical Sciences Institute, Aston University, Birmingham, UK

    A. Gescher

  3. Institute of Cancer Research, Sutton Surrey, England

    D. R. Newell

  4. Pharmaceutical Sciences, Aston University, Birmingham, UK

    M. F. G. Stevens

Authors
  1. E. Bonmassar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gescher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. R. Newell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. F. G. Stevens
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Istituto di Farmacologia, Università di Trieste, 34127, Trieste, Italy

    Tullio Giraldi

  2. Toxicology Unit, Medical Research Council, Woodmansterne Road, SM5 4EF, Carshalton, Surrey, UK

    Thomas A. Connors

  3. Divisione di Oncologia Medica, Ospedale S. Maria della Misericordia, 33100, Udine, Italy

    Giuseppe Cartei

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bonmassar, E., Gescher, A., Newell, D.R., Stevens, M.F.G. (1990). Summary of Poster-Sessions. In: Giraldi, T., Connors, T.A., Cartei, G. (eds) Triazenes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3832-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3832-5_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6710-9

  • Online ISBN: 978-1-4615-3832-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation